Biomerica, Inc. (BMRA)
NASDAQ: BMRA · Real-Time Price · USD
2.880
+0.040 (1.41%)
At close: Oct 8, 2025, 4:00 PM EDT
2.930
+0.050 (1.74%)
After-hours: Oct 8, 2025, 6:01 PM EDT
Biomerica Market Cap
Biomerica has a market cap or net worth of $8.11 million as of October 8, 2025. Its market cap has increased by 62.17% in one year.
Market Cap
8.11M
Enterprise Value
6.17M
1-Year Change
62.17%
Ranking
Category
Stock Price
$2.88
Market Cap Chart
Since August 29, 2016, Biomerica's market cap has decreased from $24.30M to $8.11M, a decrease of -66.63%. That is a compound annual growth rate of -11.34%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 8, 2025 | 8.10M | 62.00% |
| Dec 31, 2024 | 5.00M | -76.19% |
| Dec 29, 2023 | 21.00M | -53.33% |
| Dec 30, 2022 | 45.00M | -7.60% |
| Dec 31, 2021 | 48.70M | -16.75% |
| Dec 31, 2020 | 58.50M | 96.97% |
| Dec 31, 2019 | 29.70M | 92.86% |
| Dec 31, 2018 | 15.40M | -51.72% |
| Dec 29, 2017 | 31.90M | 69.68% |
| Dec 30, 2016 | 18.80M | -22.63% |
| Aug 29, 2016 | 24.30M | - |
View and export this data all the way back to 2016. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 763.77B |
| Johnson & Johnson | 454.33B |
| AbbVie | 407.14B |
| UnitedHealth Group | 333.00B |
| AstraZeneca | 266.44B |
| Novo Nordisk | 261.01B |
| Novartis AG | 255.35B |
| Abbott Laboratories | 231.08B |